使IOBR 2.0

Dongqiang Zeng1, Yiran Fang2, Wenjun Qiu2

  • 1Cancer Center, the Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, P.R. China; Foshan Key Laboratory of Translational Medicine in Oncology, the Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, P.R. China; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P.R. China.

Cell reports methods
|December 3, 2024
PubMed
概括

免疫瘤生物学研究 (IOBR) 包被升级为IOBR 2.0,增强了瘤微环境 (TME) 分析的多omics集成. 这种工具有助于理解瘤与免疫相互作用,并开发精确的免疫疗法.